47 results on '"Tirelli, U."'
Search Results
2. Use of a comprehensive geriatric assessment (CGA) to guide the use of sorafenib in unfit elderly patients (EP) with metastatic renal cell carcinoma (RCC).
3. Mortality for non-AIDS-defining cancers among people with AIDS.
4. Complete response (CR) to ifosfamide, gemcitabine, and vinorelbine (IGEV) and outcome in relapsed/refractory Hodgkin's lymphoma (HL) patients
5. The impact of HCV co-infection on the outcome and the clinical features of HIV-related non-Hodgkin lymphoma (NHL)
6. FOLFOX4 and concomitant highly active antiretroviral therapy (HAART) in metastatic colorectal cancer (M-CRC) HIV-positive patients (pts): A GICAT experience
7. Use of targeted agents in elderly cancer patients (ECP) according to the Comprehensive Geriatric Assessment (CGA)
8. Pemetrexed in second-line treatment in advanced NSCLC: An experience on 131 patients
9. Presurgical chemotherapy (CT) with FOLFOX4-regimen for patients (pts) with unresectable liver metastases (LM) from colorectal cancer (CRC)
10. Maintenance immunotherapy after autologous bone marrow transplantation (ABMT) in relapsed follicular (R-FL) and mantle cell (R-MC) lymphomas (NHL). A monoinstitutional experience
11. R-Dhaox, high dose chemotherapy (HDC) and rituximab maintenance as salvage treatment in relapsed/refractory (R/R) follicular (F) and mantle cells (MC) lymphomas (NHL)
12. Ca-15.3 antigen as predictor of response to EGFR inhibitors in patients with bronchiolo-alveolar carcinoma
13. Use of biological drugs in elderly cancer patients: A sustainable reality? A mono-institutional experience
14. Comprehensive geriatric assessment (CGA)-adapted chemotherapy (CT) in 100 elderly patients (pts) (>70 years) with diffuse large B-cell non-Hodgkin’s lymphoma (DLBCL)
15. VEBEP regimen and highly active antiretroviral terapy (HAART) in patients (pts) with HD and HIV infection (HD-HIV)
16. Factors influencing tymic function in 55 patients with lymphomas: Candidates to autologous stem cell transplantation (ASCT)
17. Cytokines modulation and activity in non-small cell lung cancer (NSCLC) by chemotherapy and indinavir
18. R-DHAOX as salvage treatment in CD20+ relapsed/refractory (R/R) non-Hodgkin lymphomas (NHL). An institutional experience
19. Effect of Lopinavir/ritonavir protease inhibitor on the pharmacokinetics of Irinotecan in HIV-infected patients with advanced Kaposi’s sarcoma
20. Cancer risk of aged people with HIV infection and of transplant people
21. Stanford V regimen in 59 patients (pts) with HD and HIV Infection (HD-HIV): A very effective approach in the long-term analysis
22. Evaluation of angiogenis activation during interleukin-2 infusion in patients with renal cell cancer (RCC)
23. HHV-8-related lymphoproliferative disorders during HIV infection: A monoinstitutional experience
24. Treatment of human immunodeficiency virus-related lymphoma with risk-adapted intensive chemotherapy: Final analysis of the NHL-HIV 93 trial
25. HAART influences the presenting characteristics and improves the outcome of patients (pts) with Hodgkin’s disease and HIV infection (HD-HIV)
26. Non-Hodgkin's lymphoma (NHL) in elderly patients (pts): Patient-tailored treatment according to a comprehensive geriatric evaluation
27. High dose therapy and autologous peripheral blood stem cell transplantation as salvage treatment for HIV-associated lymphoma
28. Lung cancer in the pre- and post-highly active antiretroviral therapy (HAART) era: A study on 61 HIV-infected patients
29. Assessment of safety and feasibility of HIV protease inhibitors (PI) as antiangiogenic agents in the treatment of advanced nasopharyngeal carcinoma (NPC)
30. Non-Hodgkin's lymphoma (NHL) in elderly patients (pts): Patient-tailored treatment according to a comprehensive geriatric evaluation
31. Lung cancer in the pre- and post-highly active antiretroviral therapy (HAART) era: A study on 61 HIV-infected patients
32. High dose therapy and autologous peripheral blood stem cell transplantation as salvage treatment for HIV-associated lymphoma
33. Assessment of safety and feasibility of HIV protease inhibitors (PI) as antiangiogenic agents in the treatment of advanced nasopharyngeal carcinoma (NPC)
34. CHOP is the standard regimen in patients > or = 70 years of age with intermediate-grade and high-grade non-Hodgkin's lymphoma: results of a randomized study of the European Organization for Research and Treatment of Cancer Lymphoma Cooperative Study Group.
35. Age and serum lactate dehydrogenase level are independent prognostic factors in human immunodeficiency virus-related non-Hodgkin's lymphomas: a single-institute study of 96 patients.
36. Testicular germ cell tumors and human immunodeficiency virus infection: a report of 26 cases. Italian Cooperative Group on AIDS and Tumors.
37. Hodgkin's disease and human immunodeficiency virus infection: clinicopathologic and virologic features of 114 patients from the Italian Cooperative Group on AIDS and Tumors.
38. Treatment of elderly patients with antineoplastic chemotherapy.
39. CD30 (Ki-1)-positive anaplastic large-cell lymphomas in 13 patients with and 27 patients without human immunodeficiency virus infection: the first comparative clinicopathologic study from a single institution that also includes 80 patients with other human immunodeficiency virus-related systemic lymphomas.
40. Human immunodeficiency virus-associated systemic lymphomas may be subdivided into two main groups according to Epstein-Barr viral latent gene expression.
41. A prospective study of a new combination chemotherapy regimen in patients older than 70 years with unfavorable non-Hodgkin's lymphoma.
42. Malignant tumors in patients with human immunodeficiency virus infection: a report of 580 cases.
43. Treatment of non-Hodgkin's lymphoma in the elderly.
44. Etoposide (VP-16-213) in malignant brain tumors: a phase II study.
45. High-dose versus low-dose cisplatin in advanced head and neck squamous carcinoma: a randomized study.
46. Treatment-related toxicity in elderly patients with malignant lymphoma.
47. Non-Hodgkin's lymphomas in 137 patients aged 70 years or older: a retrospective European Organization for Research and Treatment of Cancer Lymphoma Group Study.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.